Gordon Brier

517 total citations
19 papers, 400 citations indexed

About

Gordon Brier is a scholar working on Pharmacology, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, Gordon Brier has authored 19 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 7 papers in Molecular Medicine and 6 papers in Infectious Diseases. Recurrent topics in Gordon Brier's work include Antibiotics Pharmacokinetics and Efficacy (14 papers), Antibiotic Resistance in Bacteria (7 papers) and Antimicrobial Resistance in Staphylococcus (4 papers). Gordon Brier is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (14 papers), Antibiotic Resistance in Bacteria (7 papers) and Antimicrobial Resistance in Staphylococcus (4 papers). Gordon Brier collaborates with scholars based in United States. Gordon Brier's co-authors include Henry R. Black, J. D. Wolny, James R. Woodworth, R. S. Griffith, R. Clark Lantz, Paul M. Kovach, Karen Israel, K A DeSante, Robert L. Wolen and Boyd D. Obermeyer and has published in prestigious journals such as Nature, Annals of the New York Academy of Sciences and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Gordon Brier

18 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gordon Brier United States	11	223	123	112	108	68	19	400
Donald Pitkin United States	15	294 1.3×	90 0.7×	144 1.3×	116 1.1×	84 1.2×	33	504
J. D. Wolny United States	8	164 0.7×	109 0.9×	90 0.8×	103 1.0×	63 0.9×	11	341
P. J. Wilkinson United Kingdom	10	143 0.6×	99 0.8×	99 0.9×	109 1.0×	60 0.9×	16	353
W. E. Wick United States	11	285 1.3×	123 1.0×	166 1.5×	93 0.9×	113 1.7×	15	434
Kirby Wm	11	190 0.9×	65 0.5×	107 1.0×	48 0.4×	67 1.0×	23	365
E.A.P. Croydon Australia	8	201 0.9×	83 0.7×	65 0.6×	97 0.9×	31 0.5×	12	399
A.P. Gillett United Kingdom	10	286 1.3×	74 0.6×	156 1.4×	109 1.0×	39 0.6×	22	463
M. J. Bywater United Kingdom	16	337 1.5×	74 0.6×	228 2.0×	159 1.5×	82 1.2×	33	558
R. E. Buck United States	9	318 1.4×	71 0.6×	194 1.7×	114 1.1×	82 1.2×	16	452
S J Kohlhepp United States	15	328 1.5×	181 1.5×	116 1.0×	120 1.1×	114 1.7×	28	643

Countries citing papers authored by Gordon Brier

Since Specialization

Citations

This map shows the geographic impact of Gordon Brier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon Brier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon Brier more than expected).

Fields of papers citing papers by Gordon Brier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gordon Brier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon Brier. The network helps show where Gordon Brier may publish in the future.

Co-authorship network of co-authors of Gordon Brier

This figure shows the co-authorship network connecting the top 25 collaborators of Gordon Brier. A scholar is included among the top collaborators of Gordon Brier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gordon Brier. Gordon Brier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Woodworth, James R., et al.. (1994). Tobramycin and daptomycin disposition when co-administered to healthy volunteers. Journal of Antimicrobial Chemotherapy. 33(3). 655–659. 11 indexed citations

Woodworth, James R., et al.. (1992). Single-dose pharmacokinetics and antibacterial activity of daptomycin, a new lipopeptide antibiotic, in healthy volunteers. Antimicrobial Agents and Chemotherapy. 36(2). 318–325. 137 indexed citations

Kovach, Paul M., R. Clark Lantz, & Gordon Brier. (1991). High-performance liquid chromatographic determination of loracarbef, a potential metabolite, cefaclor and cephalexin in human plasma, serum and urine. Journal of Chromatography B Biomedical Sciences and Applications. 567(1). 129–139. 41 indexed citations

Garrett, Leland E., Richard E. Winn, Wayne P. Pierson, et al.. (1988). Capreomycin Kinetics in Renal Impairment and Clearance by Hemodialysis. American Review of Respiratory Disease. 138(5). 1312–1313. 4 indexed citations

Israel, Karen, Henry R. Black, Gordon Brier, J. D. Wolny, & K A DeSante. (1982). Single- and multiple-dose pharmacokinetics of moxalactam in normal subjects. Antimicrobial Agents and Chemotherapy. 22(1). 94–102. 6 indexed citations

DeSante, K A, et al.. (1982). Effect of probenecid on the pharmacokinetics of moxalactam. Antimicrobial Agents and Chemotherapy. 21(1). 58–61. 17 indexed citations

Aronoff, George R., et al.. (1981). Management of Amikacin Overdose. American Journal of Kidney Diseases. 1(2). 110–112. 1 indexed citations

Black, Henry R., Karen Israel, Robert L. Wolen, et al.. (1979). Pharmacology of Cinoxacin in Humans. Antimicrobial Agents and Chemotherapy. 15(2). 165–170. 23 indexed citations

Israel, Karen, et al.. (1978). Cinoxacin: Pharmacokinetics and the Effect of Probenecid. The Journal of Clinical Pharmacology. 18(10). 491–499. 15 indexed citations

10.

Griffith, R. S., Henry R. Black, Gordon Brier, & J. D. Wolny. (1977). Effect of Probenecid on the Blood Levels and Urinary Excretion of Cefamandole. Antimicrobial Agents and Chemotherapy. 11(5). 809–812. 20 indexed citations

11.

Griffith, R. S., Gordon Brier, & J. D. Wolny. (1977). Synergistic Action of Erythromycin and Cefamandole Against Bacteroides fragilis Subsp. fragilis. Antimicrobial Agents and Chemotherapy. 11(5). 813–816. 10 indexed citations

12.

Griffith, R. S., Henry R. Black, Gordon Brier, & J. D. Wolny. (1976). Cefamandole: In Vitro and Clinical Pharmacokinetics. Antimicrobial Agents and Chemotherapy. 10(5). 814–823. 64 indexed citations

13.

Brier, Gordon, et al.. (1968). L-phase bacteria in human heart tissue. Life Sciences. 7(2). 107–112. 3 indexed citations

14.

Brier, Gordon, et al.. (1967). THE INTERACTION OF ANTIBIOTICS, BACTERIA AND THE BACTERIAL L‐PHASE IN VIVO. Annals of the New York Academy of Sciences. 143(1). 760–777. 1 indexed citations

15.

Brier, Gordon, et al.. (1965). Association of Bacterial L-Phase Organisms in Chronic Infections. Nature. 205(4978). 1340–1340. 20 indexed citations

16.

Brier, Gordon, et al.. (1963). Cephalothin, a New Cephalosporin with a Broad Antibacterial Spectrum. Applied Microbiology. 11(2). 122–127. 7 indexed citations

17.

Brier, Gordon, et al.. (1963). PREDOMINANT CHARACTERISTICS OF THE GROWTH OF SOME ANTIBIOTIC-INDUCED L-PHASE BACTERIA.. PubMed. 161. 507–16.

18.

Brier, Gordon, et al.. (1963). Cephalothin, a New Cephalosporin with a Broad Antibacterial Spectrum. Applied Microbiology. 11(2). 122–127. 16 indexed citations

19.

Brier, Gordon, et al.. (1962). Bacterial L-phase growth as a possible complicating factor in certain bacteriological procedures. Life Sciences. 1(11). 565–569. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact